http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588755-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_978c7911295fd025d643a702ac408769
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb735103a93b7efbe1e02065a7a8249b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42bc9418dd253cf1a03aef2df5216592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6928f3573d335a697956b30474069260
publicationDate 2014-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103588755-A
titleOfInvention The preparation method of Neratinib
abstract The present invention relates to the preparation method of Neratinib, in particular to N-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy -6-quinolinyl]-2-phosphate diethyl ester-acetamide and dimethylaminoacetaldehyde ethylene acetal or 2-dimethylaminoacetaldehyde, in the presence of lithium salt and base, react to generate Neratinib. The method of the invention has high yield and mild reaction conditions, and the reagents used are commonly used commercially available reagents with low price, is more suitable for industrial production, and has good economic prospects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113121512-A
priorityDate 2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006127207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102020639-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467872950

Total number of triples: 18.